Literature DB >> 32280173

Predictive models for identifying risk of readmission after index hospitalization for hip arthroplasty: A systematic review.

Satish M Mahajan1, Amey Mahajan2, Chantal Nguyen3, Justin Bui4, Bruce T Abbott5, Thomas F Osborne6.   

Abstract

BACKGROUND: An aging United States population profoundly impacts healthcare from both a medical and financial standpoint, especially with an increase in related procedures such as Total Hip Arthroplasty (THA). The Hospital Readmission Reduction Program and Comprehensive Care for Joint Replacement Program incentivize hospitals to decrease post-operative readmissions by correlating reimbursements with smoother care transitions, thereby decreasing hospital burden and improving quantifiable patient outcomes. Many studies have proposed predictive models built upon risk factors for predicting 30-day THA readmissions. QUESTIONS: (1) Are there validated statistical models that predict 30-day readmissions for THA patients when appraised with a standards-based, reliable assessment tool?. (2) Which evidence-based factors are significant and have support across models for predicting risk of 30-day readmissions post-THA?
METHODS: Five major electronic databases were searched to identify studies that examined correlations between post-THA readmission and risk factors using multivariate models. We rigorously applied the PRISMA methodology and TRIPOD criteria for assessment of the prognostic studies.
RESULTS: We found 26 studies that offered predictive models, of which two presented models tested with validation cohorts. In addition to the many factors grouped into demographic, administrative, and clinical categories, bleeding disorder, higher ASA status, discharge disposition, and functional status appeared to have broad and significant support across the studies.
CONCLUSIONS: Reporting of recent predictive models establishing risk factors for 30-day THA readmissions against the current standard could be improved. Aside from building better performing models, more work is needed to follow the thorough process of undergoing calibration, external validation, and integration with existing EHR systems for pursuing their use in clinical settings. There are several risk factors that are significant in multiple models; these factors should be closely examined clinically and leveraged in future risk modeling efforts.

Entities:  

Keywords:  Hip replacement; Patient readmission; Risk factors; Statistical models; Total hip arthroplasty

Year:  2020        PMID: 32280173      PMCID: PMC7139132          DOI: 10.1016/j.jor.2020.03.045

Source DB:  PubMed          Journal:  J Orthop        ISSN: 0972-978X


  58 in total

1.  Economic burden of revision hip and knee arthroplasty in Medicare enrollees.

Authors:  K L Ong; F S Mowat; N Chan; E Lau; M T Halpern; S M Kurtz
Journal:  Clin Orthop Relat Res       Date:  2006-05       Impact factor: 4.176

2.  Economic Impact of Nonmodifiable Risk Factors in Orthopaedic Fracture Care: Is Bundled Payment Feasible?

Authors:  Siddharth A Mahure; Lorraine Hutzler; Richard S Yoon; Joseph A Bosco
Journal:  J Orthop Trauma       Date:  2017-03       Impact factor: 2.512

Review 3.  Improving Quality and Decreasing Cost by Reducing Re-admissions in Patients Undergoing Total Joint Arthroplasty.

Authors:  Daniel S Sveom; Mary K Otteman; Kevin L Garvin
Journal:  Curr Rev Musculoskelet Med       Date:  2017-09

Review 4.  Decreasing the Incidence of Surgical Site Infections Following Joint Replacement Surgery.

Authors:  Lorraine Hutzler; Jarrett Williams
Journal:  Bull Hosp Jt Dis (2013)       Date:  2017-12

5.  Readmission Rates and Diagnoses Following Total Hip Replacement in Relation to Insurance Payer Status, Race and Ethnicity, and Income Status.

Authors:  Robert S White; Dahniel L Sastow; Licia K Gaber-Baylis; Virginia Tangel; Andrew D Fisher; Zachary A Turnbull
Journal:  J Racial Ethn Health Disparities       Date:  2018-02-12

6.  Home Discharge After Primary Elective Total Joint Arthroplasty: Postdischarge Complication Timing and Risk Factor Analysis.

Authors:  Dong-Han Yao; Aakash Keswani; Chirag K Shah; Alex Sher; Karl M Koenig; Calin S Moucha
Journal:  J Arthroplasty       Date:  2016-08-27       Impact factor: 4.757

7.  Total Hip Arthroplasty in 6690 Patients with Inflammatory Arthritis: Effect of Medical Comorbidities and Age on Early Mortality.

Authors:  Rüdiger J Weiss; Göran Garellick; Johan Kärrholm; Nils P Hailer
Journal:  J Rheumatol       Date:  2016-05-01       Impact factor: 4.666

8.  Incidence of and risk factors for 30-day readmission following elective primary total joint arthroplasty: analysis from the ACS-NSQIP.

Authors:  Andrew J Pugely; John J Callaghan; Christopher T Martin; Peter Cram; Yubo Gao
Journal:  J Arthroplasty       Date:  2013-07-26       Impact factor: 4.757

9.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.

Authors:  Larissa Shamseer; David Moher; Mike Clarke; Davina Ghersi; Alessandro Liberati; Mark Petticrew; Paul Shekelle; Lesley A Stewart
Journal:  BMJ       Date:  2015-01-02

10.  Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration.

Authors:  Karel G M Moons; Douglas G Altman; Johannes B Reitsma; John P A Ioannidis; Petra Macaskill; Ewout W Steyerberg; Andrew J Vickers; David F Ransohoff; Gary S Collins
Journal:  Ann Intern Med       Date:  2015-01-06       Impact factor: 25.391

View more
  3 in total

1.  A Review of Artificial Intelligence and Robotics in Transformed Health Ecosystems.

Authors:  Kerstin Denecke; Claude R Baudoin
Journal:  Front Med (Lausanne)       Date:  2022-07-06

2.  Stepping toward outpatient total hip arthroplasty with a rapid discharge protocol.

Authors:  Paul Baker; Samantha N Andrews; Kristin Mathews; Scott Nishioka; Cass K Nakasone
Journal:  J Orthop       Date:  2021-10-02

3.  Effects of Comorbidities on Pain and Function After Total Hip Arthroplasty.

Authors:  Pingwen Lan; Xi Chen; Zhi Fang; Jianjun Zhang; Shuping Liu; Yuehong Liu
Journal:  Front Surg       Date:  2022-05-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.